<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>News (category : Partnerships and Licensing).</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Wed, 08 Feb 2012 04:13:07 +0100</pubDate>
		<lastBuildDate>Wed, 08 Feb 2012 04:13:07 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>Merck and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302</title>
			<link>http://www.lifescience-online.com/Merck_and_Threshold_Announce_Global_Agreement_to_C,30781.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/merck_kgaa,5243.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>MERCK KGAA</u></font></a><br /><a href='http://www.lifescience-online.com/threshold_pharmaceuticals,6859.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>THRESHOLD PHARMACEUTICALS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/TH-302,22804.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>TH-302</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 02 Feb 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases</title>
			<link>http://www.lifescience-online.com/Shire_and_Sangamo_Collaborate_to_Develop_Therapeut,30758.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Hematology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/shire_pharmaceuticals_group,962.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SHIRE PHARMACEUTICALS GROUP PLC</u></font></a><br /><a href='http://www.lifescience-online.com/sangamo_biosciences,6629.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SANGAMO BIOSCIENCES INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 31 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Impax Pharmaceuticals Licenses Exclusive U.S. Commercialization Rights to Zomig(R) (zolmitriptan) from AstraZeneca</title>
			<link>http://www.lifescience-online.com/Impax_Pharmaceuticals_Licenses_Exclusive_U_S__Comm,30766.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/astrazeneca,339.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ASTRAZENECA PLC</u></font></a><br /><a href='http://www.lifescience-online.com/impax_pharmaceuticals,15095.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Impax Pharmaceuticals</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/ZOLMITRIPTAN,3433.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>ZOLMITRIPTAN</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 31 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>KineMed Announces Research Collaboration With Pfizer for the Advancement of Novel Approaches in Metabolic Disease</title>
			<link>http://www.lifescience-online.com/KineMed_Announces_Research_Collaboration_With_Pfiz,30746.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/1.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/pfizer,651.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>PFIZER INC</u></font></a><br /><a href='http://www.lifescience-online.com/kinemed,9052.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>KineMed Inc</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 29 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>GenVec Inc. (GNVC) Extends Research Collaboration with Global Pharmaceutical</title>
			<link>http://www.lifescience-online.com/GenVec_Inc___GNVC__Extends_Research_Collaboration_,30733.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/genvec,681.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GENVEC INC</u></font></a><br /><a href='http://www.lifescience-online.com/global_pharmaceuticals,15096.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Global Pharmaceuticals</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 26 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Spectrum Pharmaceuticals to Acquire Worldwide Rights to Market ZEVALIN(R)</title>
			<link>http://www.lifescience-online.com/Spectrum_Pharmaceuticals_to_Acquire_Worldwide_Righ,30707.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/spectrum_pharmaceuticals,1164.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SPECTRUM PHARMACEUTICALS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/IBRITUMOMAB_TIUXETAN,3868.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>IBRITUMOMAB TIUXETAN</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 24 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Almirall and Galapagos enter a research alliance</title>
			<link>http://www.lifescience-online.com/Almirall_and_Galapagos_enter_a_research_alliance,30712.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/galapos_nv,9440.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GALAPAGOS NV</u></font></a><br /><a href='http://www.lifescience-online.com/almirall_sa,10764.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ALMIRALL SA</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 24 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Boehringer Ingelheim Corporation Prolongates Drug Discovery Collaboration With Priaxon</title>
			<link>http://www.lifescience-online.com/Boehringer_Ingelheim_Corporation_Prolongates_Drug_,30738.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/boehringer_ingelheim,5254.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>BOEHRINGER INGELHEIM CORP</u></font></a><br /><a href='http://www.lifescience-online.com/priaxon,11250.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Priaxon AG</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 23 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>
